BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30964600)

  • 1. Functionalization with a VEGFR2-binding antibody fragment leads to enhanced endothelialization of a cardiovascular stent in vitro and in vivo.
    Wawrzyńska M; Kraskiewicz H; Paprocka M; Krawczenko A; Bielawska-Pohl A; Biały D; Roleder T; Wojakowski W; O'Connor IB; Duda M; Michal R; Wasyluk Ł; Plesch G; Podbielska H; Kopaczyńska M; Wall JG
    J Biomed Mater Res B Appl Biomater; 2020 Jan; 108(1):213-224. PubMed ID: 30964600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mussel adhesive protein fused with VE-cadherin extracellular domain promotes endothelial-cell tight junctions and in vivo endothelization recovery of vascular stent.
    Yang D; Yan W; Qiu J; Huang Y; Li T; Wang Y; Wang N; Durkan C; Huang J; Yin T; Wang G
    J Biomed Mater Res B Appl Biomater; 2020 Jan; 108(1):94-103. PubMed ID: 30974041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stainless steel surface functionalization for immobilization of antibody fragments for cardiovascular applications.
    Foerster A; Hołowacz I; Sunil Kumar GB; Anandakumar S; Wall JG; Wawrzyńska M; Paprocka M; Kantor A; Kraskiewicz H; Olsztyńska-Janus S; Hinder SJ; Bialy D; Podbielska H; Kopaczyńska M
    J Biomed Mater Res A; 2016 Apr; 104(4):821-32. PubMed ID: 26566715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
    Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
    Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late endothelial progenitor cell-capture stents with CD146 antibody and nanostructure reduce in-stent restenosis and thrombosis.
    Park KS; Kang SN; Kim DH; Kim HB; Im KS; Park W; Hong YJ; Han DK; Joung YK
    Acta Biomater; 2020 Jul; 111():91-101. PubMed ID: 32434081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable Titania Nanostructures on Stainless Steel Coronary Stent Surface for Enhanced Corrosion Resistance and Endothelialization.
    Mohan CC; Cherian AM; Kurup S; Joseph J; Nair MB; Vijayakumar M; Nair SV; Menon D
    Adv Healthc Mater; 2017 Jun; 6(11):. PubMed ID: 28272784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents.
    Tang C; Wang G; Wu X; Li Z; Shen Y; Lee JC; Yu Q
    J Vasc Surg; 2011 Feb; 53(2):461-71. PubMed ID: 21129910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of paclitaxel using a drug-eluting stent through modulation of the size of drug particles in vivo.
    Jang BN; Kang SN; Eom TG; Han DK; An SH; Noh I; Kum CH
    J Biomed Mater Res B Appl Biomater; 2018 Aug; 106(6):2275-2283. PubMed ID: 29087014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell adhesive peptides functionalized on CoCr alloy stimulate endothelialization and prevent thrombogenesis and restenosis.
    Castellanos MI; Guillem-Marti J; Mas-Moruno C; Díaz-Ricart M; Escolar G; Ginebra MP; Gil FJ; Pegueroles M; Manero JM
    J Biomed Mater Res A; 2017 Apr; 105(4):973-983. PubMed ID: 28000367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct surface modification of metallic biomaterials via tyrosine oxidation aiming to accelerate the re-endothelialization of vascular stents.
    Kakinoki S; Takasaki K; Mahara A; Ehashi T; Hirano Y; Yamaoka T
    J Biomed Mater Res A; 2018 Feb; 106(2):491-499. PubMed ID: 28975703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model.
    Sedaghat A; Sinning JM; Paul K; Kirfel G; Nickenig G; Werner N
    Clin Res Cardiol; 2013 Jun; 102(6):413-25. PubMed ID: 23397592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward endothelialization via vascular endothelial growth factor immobilization on cell-repelling functional polyurethanes.
    Liao S; He Q; Yang L; Liu S; Zhang Z; Guidoin R; Fu Q; Xie X
    J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):965-977. PubMed ID: 30265778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation.
    Lan H; Wang Y; Yin T; Wang Y; Liu W; Zhang X; Yu Q; Wang Z; Wang G
    J Biomed Mater Res B Appl Biomater; 2016 Aug; 104(6):1237-47. PubMed ID: 26059710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor-bound stents: application of in situ capture technology of circulating endothelial progenitor cells in porcine coronary model.
    Takabatake S; Hayashi K; Nakanishi C; Hao H; Sakata K; Kawashiri MA; Matsuda T; Yamagishi M
    J Interv Cardiol; 2014 Feb; 27(1):63-72. PubMed ID: 24383571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
    Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
    J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
    van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care seeding of nitinol stents with blood-derived endothelial cells.
    Jantzen AE; Noviani M; Mills JS; Baker KM; Lin FH; Truskey GA; Achneck HE
    J Biomed Mater Res B Appl Biomater; 2016 Nov; 104(8):1658-1665. PubMed ID: 26340233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury.
    Wu X; Yin T; Tian J; Tang C; Huang J; Zhao Y; Zhang X; Deng X; Fan Y; Yu D; Wang G
    Regen Biomater; 2015 Jun; 2(2):87-96. PubMed ID: 26813006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving hemocompatibility and accelerating endothelialization of vascular stents by a copper-titanium film.
    Liu H; Pan C; Zhou S; Li J; Huang N; Dong L
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1175-82. PubMed ID: 27612815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.